Useful inputs
Product type, process route, target scale, ingredient classes, packaging type, broad operating ranges, non-confidential specification or test status where relevant, and the failure mode or decision under consideration.
FDE / PUBLIC SCOPE NOTE
Start with the operating boundary, not the full formula.
The early FDE batch maps non-confidential product and process signals to possible validation questions. It does not require, request, or publish exact proprietary formula information.
What the first diagnostic read can examine
FDE is a protocol-assisted manual review for early-stage functional beverage, supplement, and nutritional product systems facing a scale-up, stability, process, or chemical-specification question.
Diagnostic output
A bounded risk map across thermal, biological, chemical, mechanical, and stability layers, with critical unknowns and proportionate next validation steps. Chemical findings identify specification or testing-evidence gaps without asserting an unverified contaminant source.
Keep outside the first read
Exact ratios, complete proprietary formulas, supplier names, customer names, confidential contracts, and any information not needed to frame the operating question.
What FDE does not replace
Accredited laboratory testing, supplier audit, process engineering validation, safety testing, regulatory review, medical or nutrition claim assessment, or a guarantee of scale-up success.
How the boundary protects the work
Limited inputs make the first review easier to scope and reduce unnecessary disclosure. Any anonymized, aggregated learning is retained only when the submitter gives separate consent.